Introduction
The CXC chemokine stromal cell-derived factor-1 (SDF-1) is a potent chemoattractant for lymphoctes, monocytes, as well as hematopoietic stem-and progenitor cells, and mediates its effects through the chemokine receptor CXCR4 (LESTR, fusin). [1] [2] [3] [4] [5] [6] In contrast to other chemokines and chemokine receptors, SDF-1 and CXCR4 are more broadly expressed, and also involved in embryogenesis, including heart development, hematopoietic stem cell and neuronal cell migration, and vascular development. [7] [8] [9] Bone marrow hematopoiesis is dramatically reduced in CXCR4-or SDF-1-deficient mice, suggesting that the release of SDF-1 by bone marrow stromal cells supports the tropism of hematopoietic stem cells for the bone marrow ('homing'). 7, 8 However, SDF-1 expression is not restricted to the bone marrow, and is also found in other tissues, most likely due to constitutive production by fibroblastic stromal cells. 10 In addition to its role in the homing of hematopoietic stem cells, SDF-1 might therefore also contribute to extravasation of mononuclear cells in the absence of inflammation, particularly during lymphocyte trafficking. SDF-1 is a member of the CXC chemokine family, which is characterized by an intervening residue separating the first two cystein residues within a conserved motif. 12 The chemokine receptor CXCR4 has been shown to act as a coreceptor for the entry of the human immunodeficiency virus into CD4 + lymphocytes, which can be blocked by SDF-1. 4, 13 Other members of the CXC chemokine family (eg interleukin-8) are also potent chemoattractants for granulocytes. 14 We have shown that CXCR4 is expressed in CD34
+ hematopoietic progenitor cells including primitive, multipotential progenitors, and also variably in malignant CD34
+ myeloid precursor cells (eg acute myeloid leukemia, AML). CD34
+ progenitor cells respond to SDF-1 with increased transendothelial migration, which may contribute to bone marrow homing of hematopoietic stem cells. 6 B cell chronic lymphocytic leukemia (B-CLL) is not only the most common leukemic low-grade lymphoproliferative disorder, but also in general the most common adult leukemia in Western Europe and North America. [15] [16] [17] [18] [19] B-CLL is caused by malignant transformation of small mature B lymphocytes, characterized by expression of low surface immunoglobulins and the CD5 antigen. In addition to the considerable number of circulating malignant cells and lymph node involvement, bone marrow infiltration is consistently observed in B-CLL. Therefore, one might speculate that chemoattractants released by bone marrow stromal cells contribute to the tropism of the CLL cells for the bone marrow.
We analyzed expression of the chemokine receptor CXCR4 in circulating B-CLL cells of untreated patients. In addition, the functional effect of SDF-1 on intracellular calcium mobilization and transendothelial migration was investigated. We found that CXCR4 was highly expressed and functionally active in CLL cells from all patients. SDF-1 induced a significant release of intracellular free calcium and supported transendothelial migration of CLL cells. These findings suggest that CXCR4 and its ligand SDF-1 contribute to bone marrow infiltration frequently observed in this malignant disease.
Materials and methods

Isolation of CLL cells from the peripheral blood
Twenty-one patients with newly diagnosed or untreated (Ͼ3 months without cytotoxic treatment including steroids) chronic lymphocytic leukemia (B-CLL) were included in this analysis (male/female: 12/9; median age: 59 years, range: 41-78 years). Peripheral blood (PB) was drawn into heparinized syringes. Mononuclear cells (MNC) were isolated by Ficoll (Seromed-Biochrom, Berlin, Germany) density centrifugation. If required, monocytes were depleted by plastic adherence. Due to the high percentage of circulating B-CLL cells, further isolation of the malignant cells by immunomagnetic separation (MiniMACS, Miltenyi Biotech, Bergisch Gladbach, Germany) was not required in the majority of the samples to obtain a proportion of у90% of CLL cells (CD19
Isolation of B cells from the peripheral blood and bone marrow
After informed consent, peripheral blood of three healthy volunteers and bone marrow aliquots from three normal bone marrow donors were drawn into heparinized syringes. MNC were obtained by Ficoll (Seromed-Biochrom) density centrifugation. CD19
+ cells were further isolated by immunomagnetic separation (CD19 Microbeads and MiniMACS columns, Miltenyi Biotech). 
Flow cytometry
Measurement of intracellular free calcium mobilization
Chemokine-mediated receptor stimulation results in the mobilization of intracellular free calcium. 20 Therefore, intracellular Ca 2+ was measured using the fluorescent calcium indicator Fluo-3 (Molecular Probes, Leiden, The Netherlands), which was loaded into the cells by a method described by Vandenberghe and Ceuppens, 21 based on the loading procedure for quin2. 22 The cells (10 7 /ml) were incubated in HBSS (SigmaAldrich, Deisenhofen, Germany) containing 10 M Fluo-3 for 30 min at 37°C. After a 1:5 dilution in HBSS/1% FCS and a further incubation for 40 min at 37°C, the cells were washed three times, resuspended at a final concentration of 10 6 cells/ml in Hepes-buffered saline (137 mM NaCl, 5 mM KCI, 1 mM Na 2 HPO 4 , 5 mM glucose, 1 mM CaCl 2 , 0.5 mM MgCl 2 , 1 g/l BSA, 10 mM Hepes, pH 7.4), and incubated for 10 min at 37°C. After stimulation with SDF-1 (rhSDF-1␤, final concentration 100 ng/ml; R&D Systems, Wiesbaden, Germany), the fluorescence (FITC channel) was continuously analyzed using a FACScalibur flow cytometer (Becton Dickinson) in 5 s acquisition intervals. As a control, fluorescence changes were measured without chemokine stimulation. In some experiments, partial blocking of the CXCR4 receptor was performed by adding the CXCR4 mAb (clone 12G5, Pharmingen, final concentration 10 g/ml). Calcium fluxes were also measured in response to the CXC chemokine interleukin-8 (IL-8, rhIL-8, final concentration 100 ng/ml; PeproTech, New York, NY, USA).
Transendothelial migration
In vitro analysis of migration across endothelium was performed as described previously, 23 using the human endothelial cell line ECV304 24, 25 which was cultivated in Medium 199 (Seromed-Biochrom, Berlin, Germany), supplemented with 20% FCS (PAA Laboratories, Linz, Austria). For the transmigration experiments, ECV304 cells were seeded on 3 m transwell microporous membranes, which separate upper from lower chambers in six-well tissue culture plates (Transwell, Corning-Costar, Bodenheim, Germany), and grown to confluency. The medium was then replaced with Medium 199/5% FCS. To assess the effect of SDF-1 on transendothelial migration, SDF-1-containing conditioned medium from the bone marrow stromal cell line MS-5 was added to the lower chamber underneath the membrane as described previously, 6 and 5 × 10 5 CLL cells were placed in the upper chamber. After 14 h, the transmigrated cells were enumerated. Partially blocking CXCR4 mAb (clone 12G5, Pharmingen) was added to the cells at a final concentration of 10 g/ml. The effect of IL-8 (rhIL-8, final concentration 100 ng/ml; PeproTech), which induces efficient migration of granulocytes, was also analyzed.
In additional experiments, recombinant SDF-1 (rhSDF-1␤, R&D Systems) was added to the lower chamber of the transmigration system at a final concentration of 300 ng/ml. In these transmigration experiments, primary human umbilical vein endothelial cells (HUVEC, 4th passage, isolated and cultivated as decribed previously 26 ) were used. HUVEC were grown in Medium 199 (Seromed-Biochrom), 20% FCS (PAA Laboratories), 30 g/ml endothelial cell growth supplement (ECGS, Sigma-Aldrich), 50 g/ml heparin (Sigma-Aldrich). Migration of CLL cells from three patients and isolated CD19 + cells from three healthy volunteers were analyzed in parallel.
Statistical analysis
Data from independent experiments were expressed as mean ± s.e.m. (standard error of the mean). For the assessment of statistical significance, the parameter-free sign test for related samples (calcium fluxes) or Wilcoxon matched-pairs test (transendothelial migration) was applied. 
Results
CLL cells express high levels of CXCR4
SDF-1 induces intracellular calcium mobilization in peripheral blood CLL cells
Intracellular free calcium was measured semiquantitatively as relative Fluo-3 mean fluorescence. After application of SDF-1 (100 ng/ml), a rapid, transient flux of intracellular Ca 2+ was observed in the CLL cells, as shown in Figure 2 . As a negative control, the fluorescence changes without chemokine stimulation were also measured. The calcium fluxes in response to SDF-1 were significantly reduced by the partially blocking CXCR4 antibody 12G5. These results demonstrate that CXCR4 expressed on CLL cells was functionally active. The CXC chemokine IL-8 did not induce intracellular calcium fluxes at 100 ng/ml, which is highly reactive on granulocytes (data not shown).
Transendothelial migration of CLL cells is stimulated by SDF-1
Conditioned medium from bone marrow stromal cells (cell line MS-5) enhanced transendothelial migration of CLL cells in vitro, when added to the lower chamber of the transmigration system (Figure 3a) . The number of transmigrated cells was three-fold greater compared to random migration. Conditioned medium from bone marrow stromal cells (particularly medium from the stromal cell line MS-5) contains considerable amounts of SDF-1. 3, 5, 6 Similar results were obtained when migration of CLL cells in response to recombinant SDF-1 was analyzed (Figure 3b ). In contrast, migration of normal peripheral blood B cells in response to SDF-1 was only weak, but statistically significant. The fact that migration in response to both conditioned medium and recombinant SDF-1 was similarly reduced by the partial blocking CXCR4 mAb 12G5 (10 g/ml) demonstrated that the chemoattractant SDF-1 released by the stromal cells was responsible for the effect of 
Figure 3
In vitro transendothelial migration of CLL cells in response to SDF-1. 5 × 10 5 CLL cells were added to the upper chamber of the transmigration system. After 14 h, transmigrated cells were recovered from the lower chamber and counted. Relative transmigration was calculated by dividing the number of transmigrated CLL cells in response to chemokines by the number of spontaneously migrating CLL cells (spontaneous = fresh medium added to the lower chamber), which was measured in parallel. (a) Transendothelial migration of CLL cells was significantly enhanced, when SDF-1 containing conditioned medium was added to the lower chamber (SDF-1 CM). In addition, migration in response to SDF-1 (conditioned medium) was significantly reduced by the partially blocking CXCR4 mAb 12G5 (SDF-1 CM + mAb), indicating that the chemotactic effect of the conditioned medium was at least partially due to SDF-1 elaborated by the MS-5 stromal cells. (b) Migration of CLL cells was more efficently stimulated by recombinant SDF-1 (rhSDF-1␤, 300 ng/ml) compared to normal B cells, and was also reduced by the CXCR4 mAb 12G5 (SDF-1 + mAb). *P р 0.05; **P р 0.01; ***P р 0.001; n.s.= not significant, Wilcoxon-test. the conditioned medium on transendothelial migration of the B-CLL cells.
Discussion
In this study, we demonstrate that the chemokine receptor CXCR4 is highly expressed on leukemic B-CLL cells in a functionally active form, capable of inducing a rapid intracellular calcium flux in response to its ligand SDF-1. Moreover, transendothelial migration of CLL cells was markedly enhanced by a positive SDF-1 gradient. The expression level of CXCR4 in the malignant CD19 + /CD5
+ cells was greater than that observed in both the nonmalignant B cells of the peripheral blood and the rare normal CD19
+ /CD5 + cells of the bone marrow. Overexpression of the chemokine receptor CXCR4 has previously been observed only in B lymphoma cell lines (cell line OCI-Ly8 and DOHH-2), 6 but might frequently occur in B cell non-Hodgkin's lymphomas.
During B lymphocyte differentiation, SDF-1 appears to be functionally active preferentially in B cell precursors, 27 while CXCR4 is also expressed in mature B cells. 6, 28, 29 Recent studies suggest functional effects of SDF-1 also in more mature B cells. 28, 29 Thus, SDF-1 and CXCR4 play an inportant role in the trafficking of normal B lymphocytes and their precursors. Indeed, impaired B lymphopoiesis in SDF-1-and CXCR4-deficient mice suggests a central role of this chemokine and its receptor in B cell development. 7, 8 This hypothesis is supported by experiments analyzing bone marrow reconstitution in vivo: CXCR4−/− fetal liver cells generated much more severely reduced numbers of B cells relative to other lineages in the bone marrow. 30 Compared to normal CD5 − B cells, the expression level of CXCR4 was greater in normal CD19 + /CD5 + cells of the bone marrow, indicating that CXCR4 may play a role in the trafficking particularly of this subset. However, CXCR4 expression was still substantially greater in the malignant CLL cells.
In both primary B-CLL cells and B cell lymphoma cell lines, 6 SDF-1 was functionally active as demonstrated by the increased transendothelial migration in response to SDF-1. The amount of SDF-1 secreted by stromal cells in vitro was sufficient to significantly upregulate transendothelial migration of CLL cells, suggesting that stromal cells in vivo may also be capable of building up SDF-1 gradients that attract CXCR4 expressing cells, particularly B-CLL cells. Since the partial blocking CXCR4 antibody 12G5 similarly reduced migration in response to conditioned medium from stromal cells and in response to recombinant SDF-1, SDF-1 appeared to be the major chemotactic activity for CLL cells released in the bone marrow stroma. The CXCR4 antibody 12G5 blocks the SDF-1/CXCR4 interaction only partially. 11 In particular, calcium fluxes in response to SDF-1 are not effectively blocked. However, reduced calcium mobilization and migration in response to recombinant SDF-1 after addition of the CXCR4 antibody strongly suggests that CXCR4 is the main receptor for SDF-1 in CLL cells, which is supported by the concept that also, in general, CXCR4 is the only receptor for SDF-1. 8 This hypothesis is based on the finding that gene knockout of either SDF-1 or CXCR-4 results in the same phenotype.
From these results it can also be concluded that in vivo SDF-1 plays an important role in the hematopoietic microenvironment. SDF-1 is the predominant chemoattractant released by bone marrow stromal cells that acts on hematopoietic cells. 3, 5 Although production of SDF-1 is not confined to the bone marrow, and CXCR4 and SDF-1 are involved in embryonic and adult trafficking of non-hematopoietic cells, [7] [8] [9] 31 recent findings suggest a particular role of CXCR4 and its ligand SDF-1 in the bone marrow microenvironment. 7, 8 Indeed, transition of hematopoiesis from the fetal liver to the bone marrow critically depends on the presence of SDF-1, 7 and engraftment of human hematopoietic stem cells is impaired by CXCR4 antibodies in NOD/SCID mice. 32 It is worth noting that rather than defining a specific subpopulation, high expression of CXCR4 was consistently found on the vast majority of CLL cells from all patients analyzed. Given the fact that the expression level of CXCR4 correlates with the functional response to SDF-1, 6 and, as far as hematopoietic progenitor cells are concerned, with the avidity to enter the bone marrow microenvironment, 32 it is conceivable that B-CLL cells accumulate in the bone marrow stroma. This idea is supported by the finding that CLL cells migrate more avidly in response to SDF-1 than normal B cells.
We have recently shown that CD34 + hematopoietic progenitor cells and CXCR4-positive acute myeloid leukemia (AML) blasts derived from the bone marrow express a greater level of CXCR4 than circulating progenitors and AML blasts, respectively, 33, 34 supporting the hypothesis that continuous release of SDF-1 in the bone marrow stroma contributes to the tropism of these cells for the hematopoietic tissue. However, intraindividual comparison of CLL cells from the bone marrow and peripheral blood did not show a significant difference in the CXCR4 expression (data not shown). This might be due to the fact that in contrast to hematopoietic progenitors or AML blasts, CXCR4-low or CXCR4-negative CLL cells were virtually not detected in all patients analyzed.
Trafficking of normal T lymphocytes most likely involves interaction of CXCR4 with its ligand SDF-1.
3,11 While expression of CXCR4 has been observed in mature B cells and their precursors, 1, 6, [27] [28] [29] the role of this chemokine receptor in B-lymphocyte migration is only partially understood. Since normal B lymphocytes are also found in the bone marrow, one might assume that CXCR4 and SDF-1 are involved in the trafficking of nonmalignant B cells. Overexpression of CXCR4 in CLL cells may increase the avidity of the malignant B cells to the hematopoietic and possibly also to the lymphatic tissue, eventually leading to bone marrow infiltration and suppression of hematopoiesis, as well as lymph node and spleen enlargement.
